T1	Condition 0 17	Contraindications
T2	Procedure 22 39	spinal anesthesia
R1	AND Arg1:T1 Arg2:T2	
T3	Condition 46 64	bleeding diathesis
T4	Condition 68 86	regional infection
T5	Qualifier 90 114	site of neuroaxial block
*	OR T3 T4
T6	Scope 46 86	bleeding diathesis or regional infection
R2	Has_qualifier Arg1:T6 Arg2:T5	
T7	Condition 123 130	allergy
T8	Drug 134 145	Granisetron
T9	Drug 149 166	local anaesthetic
T10	Drug 168 185	heavy bupivacaine
T11	Drug 187 213	Marcaine Spinal 0.5% Heavy
T12	Qualifier 215 221	5mg/ml
T13	Qualifier 223 241	AstraZeneca ampule
R3	Subsumes Arg1:T10 Arg2:T11	
R4	Has_qualifier Arg1:T11 Arg2:T12	
R5	Has_qualifier Arg1:T11 Arg2:T13	
T14	Scope 168 241	heavy bupivacaine, Marcaine Spinal 0.5% Heavy, 5mg/ml, AstraZeneca ampule
*	OR T8 T9
R6	Subsumes Arg1:T9 Arg2:T14	
T15	Scope 134 242	Granisetron or local anaesthetic (heavy bupivacaine, Marcaine Spinal 0.5% Heavy, 5mg/ml, AstraZeneca ampule)
R7	Has_scope Arg1:T7 Arg2:T15	
T16	Condition 244 253	Pregnancy
T17	Condition 262 274	hypertension
T18	Qualifier 244 261	Pregnancy induced
R8	multi Arg1:T18 Arg2:T16	
R9	Has_qualifier Arg1:T17 Arg2:T18	
T19	Qualifier 276 286	Congenital
T20	Qualifier 290 299	rheumatic
T21	Condition 300 314	heart diseases
*	OR T20 T19
T22	Scope 276 299	Congenital or rheumatic
R10	Has_scope Arg1:T21 Arg2:T22	
T23	Condition 316 338	Antepartum haemorrhage
T24	Condition 340 354	Fetal destress
T25	Measurement 358 373	gestational age
T26	Value 374 383	< 36 week
R11	Has_value Arg1:T25 Arg2:T26	
*	OR T24 T25
